Alzheimer's disease and vascular factors: Facts and theories

International Journal of Clinical Practice

Volumn 56, Issue 3, 2002, Pages 197-203

  Pansari, K ^a   Gupta, A ^a   Thomas, P ^a  

^a St Davids Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ALCOHOL; AMYLOID; ANTICOAGULANT AGENT; ANTIOXIDANT; APOLIPOPROTEIN E; ARGININE; BLOOD CLOTTING FACTOR 7; CALCIUM; CHOLESTEROL; CYANOCOBALAMIN; D DIMER; ESTROGEN; FIBRINOGEN; FISH OIL; FREE RADICAL; GLUCOSE; GLUTAMIC ACID; HOMOCYSTEINE; INSULIN; LIPOPROTEIN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLASMINOGEN ACTIVATOR INHIBITOR; POTASSIUM; SOMATOMEDIN C RECEPTOR; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRAIN BLOOD FLOW; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; MALE; MICROVASCULARIZATION; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SOCIAL STATUS; STROKE; THROMBOSIS; VASCULAR DISEASE;

AGED; ALZHEIMER DISEASE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; MALE; RISK FACTORS;

EID: 0036252562     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Risk factors for vascular disease and dementia
2. Brain infarction and the clinical expression of Alzheimer's disease: The Nun study
3. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
4. Cerebral infarcts in patients with autopsy proven Alzheimer's disease: CERAD part XVIII
5. Vascular risk factors and Alzheimer's disease
6. Vascular risk factors in dementia
7. Atherosclerosis, apolipoprotein E and the prevalence of dementia and Alzheimer's disease in the Rotterdam study
8. Increased incidence of neurofibrillary tangles in non-demented individuals with hypertension
9. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischaemia in gerbils
10. Cerebral infarction is associated with severe amyloid angiopathy and hypertension
11. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: Cross sectional population based study
12. Uber eine eigenartig Erkrankung der Hirnrinde AIIg
13. Rarefied white matter in Alzheimer's disease
14. Neuropathological substrates of dementia in vascular dementia and particular focus on cases with small infarct volumes
15. Microvascular changes in Alzheimer's disease
16. Cerebral microvascular alterations in aging leukoaraiosis and Alzheimer's disease
17. Atherosclerosis: An inflammatory disease
18. A high plasma concentration of TNF-alpha is associated with dementia in centenarians
19. Arthritis and antiinflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiological studies
20. The incidence and risk of dementia: The Rotterdam study
21. Prevalence of Alzheimer's disease and vascular disease: Association with education
22. The effect of education on the incidence of dementia and Alzheimer's dementia in the Framingham study
23. Alcohol and tobacco consumption as risk factors for Alzheimer's dementia
24. Smoking and Alzheimer's dementia: Protective effect or differential survival bias?
25. Risk factors for Alzheimer's disease in Canada
26. Smoking and the risk of dementia and Alzheimer's disease in a population based cohort study: The Rotterdam study
27. Wine consumption and dementia in the elderly: A prospective community study in the Bordeaux area
28. Heavy drinking as a risk factor for depression and dementia in elderly men: The Liverpool longitudinal study
29. Reevaluating the role of vascular changes in the differential diagnosis of Alzheimer's disease and vascular dementia
30. Cognitive impairment after stroke: Frequency patterns and relationship to functional abilities
31. Risk of dementia after stroke in a hospitalised cohort: Results of a longitudinal study
32. Dementia after ischemic stroke: A population based study in Rochester Minnesota (1960-1984)
33. Severe cardiovascular disease and Alzheimer's dementia: Senile plaque formation in cortical areas
34. Cortical plaques in coronary artery disease, ageing and Alzheimer's dementia
35. Risk of cerebrovascular dysfunction in patients with probable Alzheimer's disease with APOE 4 allele
36. Cerebral vessels in ageing and Alzheimer's disease
37. Alzeimer's disease: Risk factors as related to cerebral blood flow
38. Temporal lobe perfusion on single photon emission tomography predicts the rate of cognitive decline in Alzheimer's disease
39. Cerebral hypoperfusion, capillary degeneration and development of Alzheimer's disease
40. The role of cerebral ischaemia in Alzheimer's disease
41. Low blood pressure and dementia in elderly people: The Kungsholmen project
42. Development of dementing illness in an 80 year old volunteer cohort
43. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham study
44. Midlife blood pressure and dementia: The Honolulu-Asia ageing study
45. Hypertension is related to cognitive impairment
46. 15 year longitudinal study of blood pressure and dementia
47. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal population based study
48. Effects of chronic hypertension on cognitive functioning
49. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the MRC's treatment trial of hypertension in older adults
50. Prevention of stroke by antihypertensive drug treatment in older patients with isolated systolic hypertension
51. Prevention of dementia in randomised double blind placebo controlled systolic hypertension in Europe (Sys-Eur) trial
52. Risk of dementia among persons with diabetes mellitus: A population based cohort study
53. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study
54. Glucose regulation and cognitive function: Relation to Alzheimer's disease and fiabetes mellitus
55. Advanced glycation end products in Alzheimer's disease and other neurodegenerative disease
56. Glucose intolerance, hyperinsulinemia and cognitive function in a general population of elderly men
57. Atrial fibrillation and dementia in a population based study: The Rotterdam study
58. Serum lipoprotein pattern variations in dementia and ischemic stroke
59. Serum total cholesterol, apolipoprotein E4 allele and Alzheimer's disease
60. Factors associated with vascular dementia in an elderly community population
61. Dietary fat intake and the risk of incident dementia in the Rotterdam study
62. Reduced prevalence of Alzheimer's disease associated with 3OH 3 methyglutaryl coenzyme: A reductase inhibitor
63. Statins and the risk of dementia
64. Interaction of apolipoprotein E genotype, total cholesterol, age and sex in prediction of Alzheimer's disease: A case control study
65. The relationship between apolipoprotein E, dementia and vascular illness
66. The underlying molecular mechanism of apolipoprotein E polymorphism: Relationship to lipid disorders, cardiovascular disease and Alzheimer's disease
67. Effect of age, ethnicity and head injury on the association between Apo E genotype and Alzheimer's disease
68. Association of fibrinolytic parameters with early atherosclerosis: The ARIC study
69. Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease
70. Coagulation and fibrinolysis markers and risk of dementia: The Dutch Vascular Factors in Dementia study
71. Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease?
72. Platelet activation in Alzheimer's disease
73. Estrogen therapy in post-menopausal women
74. Homocysteine and Alzheimer's dementia
75. Folate vitamin B12 and serum homocysteine levels in confirmed Alzheimer's disease
76. Total homocysteine and cognitive decline in a community based sample of elderly subjects: The Rotterdam study
77. Cognitive impairment and risk of stroke in the older population
78. Cognitive impairment and mortality in a cohort of elderly people
79. Cerebral perfusion in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension
80. Cognitive impairment and risk of stroke in the older population
81. Risk of Alzheimer's disease and duration of non steroidal anti-inflammatory drugs use
82. Vascular nitric oxide may lessen Alzheimer's risk